The comparison of the effects of a novel hydrogel compound and traditional hyaluronate following micro-fracture procedure in a rat full-thickness chondral defect model

Purpose: The aim of this experimental study was to investigate the impact of HAeCSeNAG compound(hyaluronate, sodium chondroitin sulfate, N-acetyl-D-glucosamine) on the quality of repair tissue aftermicro-fracture and to compare it with HA (hyaluronat), in a rat full-thickness chondral defect model.Methods: Full-thickness chondral defects were created in a non-weight bearing area by using a handle2.7-mm drill bit, in the right knees of 33 SpragueeDawley rats. Each specimen then underwent microfracture using a needle. Two weeks after surgery, 3 groups were randomly formed among the rats(n¼ 33). In Group 1, 0.2 mL of sterile saline solution (0.9%) was injected. In Group 2, 0.2 mL HA with amean molecular weight of 1.2 Mda was injected. In Group 3, 0.2 mL of HAeCSeNAG compound (hyaluronate, sodium chondroitin sulfate, N-acetyl-D-glucosamine) was injected. The injections were appliedon the 14th, the 21st and the 28th postoperative days. All rats were sacriŞced on the 42nd postoperativeday. Histological analysis of the repair tissue was performed for each specimen by two blinded observersusing Wakitani scoring system.Results: There was signiŞcantly improved repair tissue in both Group 3 and Group 2 when comparedwith Group 1. Group 3 showed statistically signiŞcant improvement in terms of ‘cell morphology’ and‘integration of donor with host’ when compared to Group 2 (p < 0.001).Conclusion: Intra-articular injection of HAeCSeNAG compound after micro-fracture results in signiŞcantly improved repair tissue in rats' chondral defects when compared to HA regarding the donorintegration and cell morphology.

___

1. Bedi A, Feeley BT, Williams RJ. Management of articular cartilage defects of the knee. J Bone Jt Surg Am. 2010 Apr;92(4):994e1009.

2. Steadman JR, Briggs KK, Rodrigo JJ, Kocher MS, Gill TJ, Rodkey WG. Outcomes of microfracture for traumatic chondral defects of the knee: average 11-year follow-up. Arthroscopy. 2003 MayeJun;19(5):477e484.

3. Knutsen G, Drogset JO, Engebretsen L, et al. A randomized trial comparing autologous chondrocyte implantation with microfracture. Findings at five years. J Bone Jt Surg Am. 2007 Oct;89(10):2105e2112.

4. Kreuz PC, Erggelet C, Steinwachs MR, et al. Is microfracture of chondral defects in the knee associated with different results in patients aged 40 years or younger? Arthroscopy. 2006 Nov;22(11):1180e1186.

5. Goyal D, Keyhani S, Lee EH, Hui JH. Evidence-based status of microfracture technique: a systematic review of level I and II studies. Arthroscopy. 2013 Sep;29(9):1579e1588.

6. Gobbi A, Nunag P, Malinowski K. Treatment of full thickness chondral lesions of the knee with microfracture in a group of athletes. Knee Surg Sports Traumatol Arthrosc. 2005 Apr;13(3):213e221.

7. Solheim E, Hegna J, Inderhaug E, Øyen J, Harlem T, Strand T. Results at 10-14 years after microfracture treatment of articular cartilage defects in the knee. Knee Surg Sports Traumatol Arthrosc. 2016 May;24(5):1587e1593.

8. Gudas R, Gudaite A, Pocius A, et al. Ten-year follow-up of a prospective, randomized clinical study of mosaic osteo-chondral autologous transplantation versus microfracture for the treatment of osteochondral defects in the knee joint of athletes. Am J Sports Med. 2012 Nov;40(11):2499e2508.

9. Mithoefer K, McAdams T, Williams RJ, Kreuz PC, Mandelbaum BR. Clinical ef- ficacy of the microfracture technique for articular cartilage repair in the knee: an evidence-based systematic analysis. Am J Sports Med. 2009 Oct;37(10): 2053e2063.

10. Steadman JR, Rodkey WG, Rodrigo JJ. Microfracture: surgical technique and rehabilitation to treat chondral defects. Clin Orthop Relat Res. 2001 Oct;391(Suppl):362e369.

11. Saris DB, Vanlauwe J, Victor J, et al. Treatment of symptomatic cartilage defects of the knee: characterized chondrocyte implantation results in better clinical outcome at 36 months in a randomized trial compared to microfracture. Am J Sports Med. 2009 Nov;37(Suppl 1):10se19s.

12. Steadman JR, Briggs KK, Matheny LM, Guillet A, Hanson CM, Willimon SC. Outcomes following microfracture of full-thickness articular cartilage lesions ofthe knee in adolescent patients. J Knee Surg. 2015 Apr;28(2):145e150.

13. Gille J, Schuseil E, Wimmer J, Gellissen J, Schulz AP, Behrens P. Mid-term resultsof Autologous Matrix-Induced Chondrogenesis for treatment of focal cartilagedefects in the knee. Knee Surg Sports Traumatol Arthrosc. 2010 Nov;18(11):1456e1464.

14. Tuncay I, Erkocak OF, Acar MA, Toy H. The effect of hyaluronan combined withmicrofracture on the treatment of chondral defects: an experimental study in arabbit model. Eur J Orthop Surg Traumatol. 2013 Oct;23(7):753e758.

15. Wakitani S, Kawaguchi A, Tokuhara Y, Takaoka K. Present status of and future direction for articular cartilage repair. J Bone Miner Metab. 2008 Mar;26(2): 115e122.

16. Strauss E, Schachter A, Frenkel S, Rosen J. The efficacy of intra- articular hyaluronan injection after the microfracture technique for the treatment of articular cartilage lesions. Am J Sports Med. 2009 Apr;37(4):720e726.

17. Park YS, Lim SW, Lee IH, Lee TJ, Kim JS, Han JS. Intra-articular injection of a nutritive mixture solution protects articular cartilage from osteoarthritic progression induced anterior cruciate ligament transection in mature rabbits: a randomized controlled trial. Arthritis Res Ther. 2007 Jan;9(1):R8.

18. Abramson S. Drug delivery in degenerative joint disease: where we are and where to go? Adv Drug Deliv Rev. 2006 May 20;58(2):125e127.

19. Sukur E, Talu C, Akman YE, Circi E, Ozturkmen Y, Tuzuner T. Comparison of the chondroprotective effect of a novel hydrogel compound and traditional hyaluronate on rat cartilage in a papain-induced osteoarthritis model. Acta Orthop Traumatol Turc. 2016 Aug;50(4):458e463.

20. Wakitani S, Goto T, Pineda SJ, et al. Mesenchymal cell-based repair of large,full-thickness defects of articular cartilage. J Bone Jt Surg Am. 1994 Apr;76(4):579e592.

21. Ando A, Hagiwara Y, Chimoto E, Hatori K, Onoda Y, Itoi E. Intra-articular injection of hyaluronan diminishes loss of chondrocytes in a rat immobilizedknee model. Tohoku J Exp Med. 2008 Aug;215(4):321e331.

22. Peng H, Zhou JL, Liu SQ, Hu QJ, Ming JH, Qiu B. Hyaluronic acid inhibits nitric oxide-induced apoptosis and dedifferentiation of articular chondrocytes in vitro. Inflamm Res. 2010 Jul;59(7):519e530.

23. Shikhman A, Chantaphakul H, Brinson DC, Lotz M. Effect of N-acetylglucosamine on hyaluronic acid production in human articular chondrocytes and synovial fibroblasts [abstract]. Osteoarthr Cartil. 2000 Mar;8(suppl B):S54.

24. Shikhman AR, Kuhn K, Alaaeddine N, Lotz M. N-acetylglucosamine prevents IL- 1 beta mediated activation of human chondrocytes. J Immunol. 2001 Apr 15;166(8):5155e5160.

25. Bishnoi M, Jain A, Hurkat P, Jain SK. Chondroitin sulphate: a focus on osteoarthritis. Glycoconj J. 2016 Oct;33(5):693e705.

26. Chan PS, Caron JP, Orth MW. Effect of glucosamine and chondroitin sulfate onregulation of gene expression of proteolytic enzymes and their inhibitors ininterleukin-1-challenged bovine articular explants. Am J Vet Res. 2005 Nov;66(11):1870e1876.

27. Yue XL, Lehri S, Barbier-Chassefiere V, et al. Insights on a new path of premitochondrialapoptosis regulation by a glycosaminoglycan mimetic. CellDeath Differ. 2009 May;16(5):770e781.

28. Martel-Pelletier J, Kwan Tat S, Pelletier JP. Effects of chondroitin sulfate in thepathophysiology of the osteoarthritic joint: a narrative review. OsteoarthrCartil. 2010 Jun;18(Suppl 1):S7eS11.

29. David-Raoudi M, Deschrevel B, Leclercq S, Galera P, Boumediene K, Pujol JP. Chondroitin sulfate increases hyaluronan production by human synoviocytesthrough differential regulation of hyaluronan synthases: role of p38 and Akt.Arthritis Rheum. 2009 Mar;60(3):760e770.

30. Hui JH, Chan SW, Li J, et al. Intra-articular delivery of chondroitin sulfate for thetreatment of joint defects in rabbit model. J Mol Histol. 2007 Oct;38(5):483e489.

31. Du Souich P. Absorption, distribution and mechanism of action of SYSADOAS.Pharmacol Ther. 2014 Jun;142(3):362e374.

32. Hathcock JN, Shao A. Risk assessment for glucosamine and chondroitin sulfate.Regul Toxicol Pharmacol. 2007 Feb;47(1):78e83.

33. Hwang JS, Park JW, Nam MS, Cho H, Han IO. Glucosamine enhances bodyweight gain and reduces insulin response in mice fed chow diet but mitigatesobesity, insulin resistance and impaired glucose tolerance in mice high-fat diet.Metabolism. 2015 Mar;64(3):368e379.

34. Clegg DO, Reda DJ, Harris CL, et al. Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis. New Engl J Med. 2006 Feb23;354(8):795e808.

35. Murphy RK, Ketzler L, Rice RD, Johnson SM, Doss MS, Jaccoma EH. Oralglucosamine supplements as a possible ocular hypertensive agent. JAMAOphthalmol. 2013 Jul;131(7):955e957.

36. Conrozier T, Chevalier X. Long-term experience with hylan GF-20 in thetreatment of knee osteoarthritis. Expert Opin Pharmacother. 2008 Jul;9(10):1797e1804.

37. Conrozier T, Jerosch J, Beks P, et al. Prospective, multi-centre, randomised evaluation of the safety and efficacy of five dosing regimens of viscosupplementation with hylan G-F 20 in patients with symptomatic tibio-femoral osteoarthritis: a pilot study. Arch Orthop Trauma Surg. 2009 Mar;129(3): 417e423.

38. Shikhman AR, Amiel D, D'Lima D, et al. Chondroprotective activity of N-acetylglucosamine in rabbits with experimental osteoarthritis. Ann Rheum Dis. 2005 Jan;64(1):89e94.

39. Henrotin Y, Marty M, Mobasheri A. What is the current status of chondroitinsulfate and glucosamine for the treatment of knee osteoarthritis? Maturitas.2014 Jul;78(3):184e187.
Acta Orthopaedica et Traumatologica Turcica-Cover
  • ISSN: 1017-995X
  • Başlangıç: 2015
  • Yayıncı: Türk Ortopedi ve Travmatoloji Derneği
Sayıdaki Diğer Makaleler

A comparison of rat degloving injury models

SERDAR ALTUN, Hakan ORBAY, Mehmet EKİNCİ, Ahmet ÇETİNBAŞ, Ali BAL, Enver ARPACI, Mehmet Ihsan OKUR

The timing and importance of motor skills course in knee arthroscopy training

Engin ÇETİNKAYA, Hakan ÇİFT, Ahmet AYBAR, Ersin ERÇİN, Gamze GÜLER BABÜR, OĞUZ ŞÜKRÜ POYANLI

Do hand outcome measures reflect cultural influences?

ÇİĞDEM ÖKSÜZ, BURCU SEMİN AKEL, ORKUN TAHİR ARAN, Ilkem Ceren SIĞIRTMAÇ, A.Gürsel LEBLEBİCİOĞLU

Evidence for reliability, validity and responsiveness of Turkish version of Hip Outcome Score

GÖKHAN POLAT, DERYA ÇELİK, Hilal ÇİL, Mehmet ERDİL, MEHMET AŞIK

Volar dislocation of the metacarpophalangeal joint of the thumb: A case report

Serdar YÜKSEL, Oktay ADANIR, Ozan BEYTEMÜR, MEHMET AKİF GÜLEÇ

The comparison of the effects of a novel hydrogel compound and traditional hyaluronate following micro-fracture procedure in a rat full-thickness chondral defect model

Yunus Emre AKMAN, Erhan ŞÜKÜR, Ahmet ŞENEL, Nur Ece OZTAS SUKUR, ESRA CANAN KELTEN TALU, YUSUF ÖZTÜRKMEN

Total joint replacement for neglected posterior knee dislocation following septic arthritis after arthroscopy

YUSUF ÖZTÜRKMEN, Yunus Emre AKMAN, Ethem Ayhan ÜNKAR, Erhan ŞÜKÜR

Evaluation of thoracic vertebrae rotation in patients with pectus excavatum

Ryszard TOMASZEWSKİ, Lukasz WİKTOR, Ludwina MACHALA

Epithelioid hemangioendothelioma of the craniocervical junction; case report and review

Ali Ender OFLUOĞLU, Mehmet AYDOĞAN, Uzay ERDOĞAN, Önder OFLUOĞLU

The relation between elbow range of motion and patient satisfaction after open release of stiff elbow

Hakan GÜNDEŞ, ÖZGÜR SELEK, Ümit GÖK, Bora GÜMÜŞLÜ, Levent BULUÇ